Phase 3 trial

March 5, 2018March 5, 2018

Genervon Continues to Focus on Nerve Cell Development Factor as ALS Treatment

News

Genervon Biopharmaceuticals says its efforts to develop treatments for ALS and other neurodegenerative diseases continue to focus on a factor that regulates stem cells’ evolution into nerve cells. It continues ... Read more

July 19, 2017

Boston and San Francisco Hospitals Will Take Part in Phase 3 Trial of NurOwn for ALS

News

Massachusetts General Hospital in Boston and California Pacific Medical Center in San Francisco will be among the sites where ALS patients will take in a Phase 3 clinical trial of BrainStorm Cell ... Read more

July 7, 2017

Worldwide Clinical Trials Picked to Manage Phase 3 Study of NurOwn for ALS

News

Worldwide Clinical Trials was selected as the Clinical Research Organization (CRO) to run a Phase 3 study of the investigational stem-cell therapy NurOwn for the treatment of amyotrophic lateral sclerosis (ALS). BrainStorm Cell ... Read more

April 26, 2016April 26, 2016

Clinical Data of Promising ALS Drug Edaravone Presented at AAN Annual Meeting

News

Results from the Phase 3 trial of edaravone (MCI-186) in amyotrophic lateral sclerosis (ALS) were presented by Mitsubishi Tanabe Pharma Corporation at the 68th Annual Meeting of the American Academy of Neurology held April 15-21 in Vancouver, ... Read more

April 12, 2016April 12, 2016

AB Science Reviews Ongoing Phase 3 Study of Masitinib as ALS Treatment in Conference with Experts

News

AB Science recently reported positive data from an interim analysis of a Phase 2/3 study of masitinib, its lead compound to treat amyotrophic lateral sclerosis (ALS). The company also held a web ... Read more

Pin It on Pinterest